Weiss Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Weiss Asset Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-700,000	Closed	-$28.2M	–	643
2026 Q1	$28.2M	Buy	+700,000	New	+$15.1M	0.47%	39
2024 Q1	–	Sell	-10,677	Closed	-$639K	–	322
2023 Q4	$639K	Buy	+10,677	New	+$542K	0.03%	191

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Weiss Asset Management's APLS Position: Q2 2026 in Review

Weiss Asset Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 700,000 shares — an estimated $28.2M sold.

Weiss Asset Management first reported a position in APLS in Q4 2023 and held it in 2 quarters. The position peaked at $28.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Weiss Asset Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Weiss Asset Management sold 700,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $28.2M.
Weiss Asset Management first reported a position in Apellis Pharmaceuticals in Q4 2023 and held it in 2 quarters.
Weiss Asset Management's Apellis Pharmaceuticals position peaked at $28.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.